The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)
Official Title: A Randomized, Double-blind, Multi-center Phase III Study Comparing Everolimus (RAD001) Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Patients With Advanced Gastric Cancer After Progression on 1 or 2 Prior Systemic Chemotherapy
Study ID: NCT00879333
Brief Summary: This study is designed to assess the safety and efficacy of RAD001 monotherapy in patients with advanced gastric cancer which has progressed after one or two lines of prior chemotherapy.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Highlands Oncology Group DeptofHighlandsOncologyGrp(2), Fayetteville, Arkansas, United States
Loma Linda Oncology Medical Group Loma Linda, Redlands, California, United States
Henry Ford Hospital Dept. of Henry Ford Hospital, Detroit, Michigan, United States
University of Minnesota Cancer Center, Minneapolis, Minnesota, United States
University of Texas Southwestern Medical Center DeptofSimmons Cancer Center(4), Dallas, Texas, United States
The Center for Cancer and Blood Disorders Dept. of The Ctr for C & BD(2), Fort Worth, Texas, United States
University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology, Houston, Texas, United States
University of Washington Cancer Care Seattle Cancer Alliance, Seattle, Washington, United States
Novartis Investigative Site, Rio Negro, Viedma, Argentina
Novartis Investigative Site, Buenos Aires, , Argentina
Novartis Investigative Site, Cordoba, , Argentina
Novartis Investigative Site, Canberra, Australian Capital Territory, Australia
Novartis Investigative Site, Herston, Queensland, Australia
Novartis Investigative Site, Kurralta Park, South Australia, Australia
Novartis Investigative Site, North Adelaide, South Australia, Australia
Novartis Investigative Site, Box Hill, Victoria, Australia
Novartis Investigative Site, Clayton, Victoria, Australia
Novartis Investigative Site, Footscray, Victoria, Australia
Novartis Investigative Site, Heidelberg, Victoria, Australia
Novartis Investigative Site, Prahran, Victoria, Australia
Novartis Investigative Site, Charleroi, , Belgium
Novartis Investigative Site, Gent, , Belgium
Novartis Investigative Site, Leuven, , Belgium
Novartis Investigative Site, Liege, , Belgium
Novartis Investigative Site, North Vancouver, British Columbia, Canada
Novartis Investigative Site, Vancouver, British Columbia, Canada
Novartis Investigative Site, Toronto, Ontario, Canada
Novartis Investigative Site, Toronto, Ontario, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Sherbrooke, Quebec, Canada
Novartis Investigative Site, Guangzhou, Guangdong, China
Novartis Investigative Site, Shijiazhuang, Hebei, China
Novartis Investigative Site, Harbin, Heilongjiang, China
Novartis Investigative Site, Nanjing, Jiangsu, China
Novartis Investigative Site, Suzhou, Jiangsu, China
Novartis Investigative Site, Shenyang, Liaoning, China
Novartis Investigative Site, Chengdu, Sichuan, China
Novartis Investigative Site, Hangzhou, Zhejiang, China
Novartis Investigative Site, Beijing, , China
Novartis Investigative Site, Beijing, , China
Novartis Investigative Site, Guangzhou, , China
Novartis Investigative Site, Shanghai, , China
Novartis Investigative Site, Shanghai, , China
Novartis Investigative Site, Shanghai, , China
Novartis Investigative Site, Avignon Cedex, , France
Novartis Investigative Site, Clermont Ferrand cedex 1, , France
Novartis Investigative Site, Clichy, , France
Novartis Investigative Site, Dijon, , France
Novartis Investigative Site, Lyon Cedex 08, , France
Novartis Investigative Site, Marseille cedex 05, , France
Novartis Investigative Site, Montpellier Cedex 5, , France
Novartis Investigative Site, Nice Cedex 2, , France
Novartis Investigative Site, Paris, , France
Novartis Investigative Site, Pessac Cedex, , France
Novartis Investigative Site, Poitiers, , France
Novartis Investigative Site, Reims, , France
Novartis Investigative Site, Rennes Cedex, , France
Novartis Investigative Site, Toulouse Cedex 4, , France
Novartis Investigative Site, Villejuif Cedex, , France
Novartis Investigative Site, Mannheim, Baden-Württemberg, Germany
Novartis Investigative Site, Berlin, , Germany
Novartis Investigative Site, Bielefeld, , Germany
Novartis Investigative Site, Frankfurt, , Germany
Novartis Investigative Site, Mainz, , Germany
Novartis Investigative Site, München, , Germany
Novartis Investigative Site, Offenburg, , Germany
Novartis Investigative Site, Trier, , Germany
Novartis Investigative Site, Hong Kong SAR, , Hong Kong
Novartis Investigative Site, Jerusalem, , Israel
Novartis Investigative Site, Petach Tikva, , Israel
Novartis Investigative Site, Ramat Gan, , Israel
Novartis Investigative Site, Rehovot, , Israel
Novartis Investigative Site, Firenze, FI, Italy
Novartis Investigative Site, Rozzano, MI, Italy
Novartis Investigative Site, Modena, MO, Italy
Novartis Investigative Site, Aviano, PN, Italy
Novartis Investigative Site, Frattamaggiore, , Italy
Novartis Investigative Site, Nagoya, Aichi, Japan
Novartis Investigative Site, Kashiwa, Chiba, Japan
Novartis Investigative Site, Matsuyama, Ehime, Japan
Novartis Investigative Site, Fukuoka-city, Fukuoka, Japan
Novartis Investigative Site, Sapporo-city, Hokkaido, Japan
Novartis Investigative Site, Sagamihara, Kanagawa, Japan
Novartis Investigative Site, Sendai-city, Miyagi, Japan
Novartis Investigative Site, OsakaSayama, Osaka, Japan
Novartis Investigative Site, Takatsuki-city, Osaka, Japan
Novartis Investigative Site, Kitaadachi-gun, Saitama, Japan
Novartis Investigative Site, Utsunomiya, Tochigi, Japan
Novartis Investigative Site, Chuo-ku, Tokyo, Japan
Novartis Investigative Site, Koto, Tokyo, Japan
Novartis Investigative Site, Mitaka-city, Tokyo, Japan
Novartis Investigative Site, Jeonju-si, Jeollabuk-do, Korea, Republic of
Novartis Investigative Site, Seoul, Korea, Korea, Republic of
Novartis Investigative Site, Seoul, Korea, Korea, Republic of
Novartis Investigative Site, Seoul, Korea, Korea, Republic of
Novartis Investigative Site, Seoul, Korea, Korea, Republic of
Novartis Investigative Site, Seoul, , Korea, Republic of
Novartis Investigative Site, Taegu, , Korea, Republic of
Novartis Investigative Site, México, Distrito Federal, Mexico
Novartis Investigative Site, León, Guanajuato, Mexico
Novartis Investigative Site, Amsterdam, , Netherlands
Novartis Investigative Site, Auckland, , New Zealand
Novartis Investigative Site, San Borja, Lima, Peru
Novartis Investigative Site, San Isidro, Lima, Peru
Novartis Investigative Site, Moscow, , Russian Federation
Novartis Investigative Site, St. Petersburg, , Russian Federation
Novartis Investigative Site, Barcelona, Catalunya, Spain
Novartis Investigative Site, Kuei-Shan Chiang, Taoyuan/ Taiwan ROC, Taiwan
Novartis Investigative Site, Liouying Township, , Taiwan
Novartis Investigative Site, Niaosong Township, , Taiwan
Novartis Investigative Site, Taipei, , Taiwan
Novartis Investigative Site, Taipei, , Taiwan
Novartis Investigative Site, Bangkok, , Thailand
Novartis Investigative Site, Bangkok, , Thailand
Novartis Investigative Site, Songkla, , Thailand
Novartis Investigative Site, Northwood, Middlesex, United Kingdom
Novartis Investigative Site, Sutton, Surrey, United Kingdom
Novartis Investigative Site, East Yorkshire, , United Kingdom
Novartis Investigative Site, London, , United Kingdom
Novartis Investigative Site, London, , United Kingdom
Novartis Investigative Site, Manchester, , United Kingdom
Novartis Investigative Site, Wolverhampton, , United Kingdom
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR